Globus Medical Inc. (GMED)

NYSE: GMED · Real-Time Price · USD

86.91

+1.24 (1.45%)

At close: Aug 21, 2026, 8:00 PM

86.91

+0.00%

After-hours: 7:30 PM

The price, the headline numbers and the latest news, in one place.

1.45% (1D)

No data available

Bid	86.56
Market Cap	11.67B
Revenue (ttm)	3.14B
Net Income (ttm)	535.43M
	0.95
	3.91
	22.23
	16.2
P/B (ttm)	2.49
P/S (ttm)	3.71
Earnings Date	Nov 5, 2026

Ask	86.76
Volume	651,820
Avg. Volume (20D)	1,700,343
Open	85.57
Previous Close	85.67
Day's Range	85.26 - 87.16
52-Week Range	54.15 - 101.40
Analyst	n/a
Price Target	n/a
Dividends	n/a
Ex-Dividend Date	n/a

About GMED

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, ...

[Read more]

Industry Medical Devices

Sector Healthcare

IPO Date Aug 3, 2012

Employees 6,000

Stock Exchange NYSE

Ticker Symbol GMED

Website https://www.globusmedical.com

Full Company Profile

Financial Performance

In 2025, Globus Medical's revenue was 2.94B, an increase of 16.65% compared to the previous year's 2.52B. Earnings were 537.87M, an increase of 422.28%.

Financial Statements